1. Home
  2. JNJ
  3. JNJ News

Latest Johnson & Johnson (JNJ) News on July 2, 2024

J&J looks to challenge argenx’s Vyvgart with positive Phase III data

Pharmaceutical Technology

a day ago

J&J looks to challenge argenx’s Vyvgart with positive Phase III data

MT Newswires

21 days ago

Sector Update: Health Care

Share on Social Networks: